Pharmaceutical Ingredient API Raw Material 99% Purity Powder CAS 304-20-1 Hydralazine HCl/Hydralazine Hydrochloride with Best Price

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: A-206
• Certification: ISO 9001, USP, BP
• Suitable for: Adult
• State: Powder
• Purity: >99%
• Sample: Available
• MOQ: 10g
• Appearance: White Powder
• Assay: 99%
• Test Method: HPLC
• Shelf Life: 2 Years
• Storage: Cool&Dry Places
• Packing: 1kg/Bag; 25kg/Drum
• CAS No.: 304-20-1
• Molecular Formula: C8h9cln4
• Molecular Weight: 196.64
• Grade: Pharmaceutical Grade
• Application: Pharmaceutical
• Coa: Available
• MSDS: Available
• Transport Package: 1kg/Bag; 25kg/Drum
• Specification: 1kg/Bag; 25kg/Drum
• Trademark: Greenway
• Origin: Jiangsu
• HS Code: 2942000000
• Production Capacity: 100kg/Week

Product Description

Product Name	Hydralazine Hydrochloride
CAS No.	304-20-1
Molecular Formula	C8H9ClN4
Molecular Weight	196.64
Appearance	White Powder
Assay	99%
Grade	Pharmaceutical Grade
Brand	Greenway

Product Introduction:
Hydralazine is a medication used to treat high blood pressure and heart failure. This includes high blood pressure in pregnancy and very high blood pressure resulting in symptoms. It has been found to be particularly useful in heart failure together with isosorbide dinitrate in people of African descent. It is given by mouth or by injection into a vein. Effects usually begin around 15 minutes and last up to six hours.

Hydralazine is not used as a primary drug for treating hypertension because it elicits a reflex sympathetic stimulation of the heart (the baroreceptor reflex). The sympathetic stimulation may increase heart rate and cardiac output, and in people with coronary artery disease may cause angina pectoris or myocardial infarction. Hydralazine may also increase plasma renin concentration, resulting in fluid retention. To prevent these undesirable side effects, hydralazine is usually prescribed in combination with a β-blocker (e.g., pranolol) and a diuretic. Beta-blockers licensed to treat heart failure in the UK include biso-prolol, carve-dilol, and nebivolol.